Lysyl oxidase assists tumor‑initiating cells to enhance angiogenesis in hepatocellular carcinoma.
暂无分享,去创建一个
Wei Zhao | Z. Tian | Zhongwu Li | B. Ma | Boqing Wang | Min Yang | Fei Wang | Jingtao Liu
[1] K. Coral,et al. Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide , 2018, Scientific Reports.
[2] I. Ng,et al. Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer , 2018, Oncogenesis.
[3] E-C Kim,et al. Lysyl oxidase‐mediated VEGF‐induced differentiation and angiogenesis in human dental pulp cells , 2018, International endodontic journal.
[4] Jie He,et al. Cancer incidence and mortality in China, 2014. , 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[5] Xiangpeng Yuan,et al. Subpopulations of cancer stem cells found in papillary thyroid carcinoma , 2018, Experimental cell research.
[6] S. Sajdak,et al. Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer. , 2017, European journal of medicinal chemistry.
[7] Qun Wang,et al. Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma , 2017, Molecules and cells.
[8] P. Kornprat,et al. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types , 2017, PloS one.
[9] Z. Zeng,et al. Trend analysis of cancer incidence and mortality in China , 2017, Science China Life Sciences.
[10] Jin-Chul Ahn,et al. Adipose-derived stem cell spheroid treated with low-level light irradiation accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. , 2017, Cytotherapy.
[11] Chad J. Creighton,et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.
[12] N. Gellrich,et al. CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo. , 2017, Microvascular research.
[13] Pedro Fonseca,et al. A novel community driven software for functional enrichment analysis of extracellular vesicles data , 2017, Journal of extracellular vesicles.
[14] O. Okamoto,et al. Inhibition of Lysyl Oxidases Impairs Migration and Angiogenic Properties of Tumor-Associated Pericytes , 2017, Stem cells international.
[15] Y. Zhen,et al. A CD13‐targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis , 2017, Molecular carcinogenesis.
[16] R. Jain,et al. Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors , 2017, Scientific Reports.
[17] T. Tian,et al. Hypoxia triggers angiogenesis by increasing expression of LOX genes in 3‐D culture of ASCs and ECs , 2017, Experimental cell research.
[18] G. Facchini,et al. Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma , 2016, Front. Pharmacol..
[19] G. Du,et al. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway , 2016, BMC Cancer.
[20] Ming-jun Wang,et al. Increased serum levels of tumor necrosis factor receptor-associated factor 1 (TRAF1) correlate with disease activity and autoantibodies in rheumatoid arthritis. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[21] J. Trojan,et al. Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma , 2016, Journal of hepatocellular carcinoma.
[22] P. Zhu,et al. Inhibition of Lysyl Oxidase by Cortisol Regeneration in Human Amnion: Implications for Rupture of Fetal Membranes. , 2016, Endocrinology.
[23] M. Koupenova,et al. Lysyl oxidase is associated with increased thrombosis and platelet reactivity. , 2016, Blood.
[24] Tao Yin,et al. Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment , 2016, Molecular medicine reports.
[25] Y. Inagaki,et al. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma. , 2015, World journal of gastroenterology.
[26] D. Ribatti,et al. Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease , 2015, Angiogenesis.
[27] R. Finn. Treatment of Intermediate-Stage Hepatocellular Carcinoma. , 2015, Gastroenterology & hepatology.
[28] H. Nakagawa,et al. A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma , 2015, Cancer biology & therapy.
[29] Shan Huang,et al. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma , 2015, Digestive Diseases and Sciences.
[30] Z. Werb,et al. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.
[31] Wei Zhao,et al. Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 , 2014, Molecular Cancer.
[32] Haichuan Li,et al. Vasostatin Inhibits VEGF-Induced Endothelial Cell Proliferation, Tube Formation and Induces Cell Apoptosis under Oxygen Deprivation , 2014, International journal of molecular sciences.
[33] J. Huse,et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.
[34] Xiangnan Li,et al. Metronomic gemcitabine targeted tumor vascular microenvironment decreases the population of CD133(+) cells in hepatocarcinoma xenografts. , 2014, Cancer biomarkers : section A of Disease markers.
[35] N. Shinohara,et al. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis , 2013, British Journal of Cancer.
[36] V. Weaver,et al. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas. , 2013, Cancer research.
[37] G. Semenza. Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis , 2013, Oncogene.
[38] M. Ringnér,et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development , 2013, Proceedings of the National Academy of Sciences.
[39] Wei Zhao,et al. 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit. , 2013, Cancer cell.
[40] Motoko Sasaki,et al. Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C , 2013, Clinical Cancer Research.
[41] W. Guo,et al. Angiogenesis inhibition and cell cycle arrest induced by treatment with Pseudolarix acid B alone or combined with 5-fluorouracil. , 2012, Acta biochimica et biophysica Sinica.
[42] Jing Wu,et al. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling , 2010, Proceedings of the National Academy of Sciences.
[43] M. Caraglia,et al. Latest developments in targeted therapy for hepatocellular carcinoma , 2010, Expert review of anticancer therapy.
[44] Wei Zhao,et al. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. , 2010, Carcinogenesis.
[45] A. Albini,et al. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. , 2003, Cancer detection and prevention.
[46] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[47] A. Rowan. Guide for the Care and Use of Laboratory Animals , 1979 .
[48] F W MULSOW,et al. Cancer incidence and mortality , 2019, Health at a Glance: Europe.